Blockade of Type I Interferon (IFN) Production by Retroviral Replicating Vectors and Reduced Tumor Cell Responses to IFN Likely Contribute To Tumor Selectivity-Reference-Cited by-同舟云学术

Blockade of Type I Interferon (IFN) Production by Retroviral Replicating Vectors and Reduced Tumor Cell Responses to IFN Likely Contribute To Tumor Selectivity

Published:2014-06-25 Issue:17 Volume:88 Page:10066-10077
ISSN:0022-538X
Container-title:Journal of Virology
language:en
Short-container-title:Journal of Virology

Author:

Lin A. H.,Burrascano C.,Pettersson P. L.,Ibanez C. E.,Gruber H. E.,Jolly D. J.

Publisher

American Society for Microbiology

Subject

Virology,Insect Science,Immunology,Microbiology

Reference44 articles.

1. The case of oncolytic viruses versus the immune system: waiting on the judgment of Solomon;Prestwich;Hum. Gene Ther.,2009

2. Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector;Ostertag;Neuro Oncol.,2012

3. Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model;Wang;Neurosurg. Focus,2006

4. Amphotropic murine leukemia retrovirus is not an acute pathogen for primates;Cornetta;Hum. Gene Ther.,1990

5. Design and selection of Toca 511 for clinical use: modified retroviral replicating vector with improved stability and gene expression;Perez;Mol. Ther.,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA-detargeting proves more effective than leader gene deletion for improving safety of oncolytic Mengovirus in a nude mouse model;Molecular Therapy - Oncolytics;2021-12

2. The transcriptional landscape of Venezuelan equine encephalitis virus (TC-83) infection;PLOS Neglected Tropical Diseases;2021-03-31

3. Using viral vectors to deliver local immunotherapy to glioblastoma;Neurosurgical Focus;2021-02

4. Immunologic aspects of viral therapy for glioblastoma and implications for interactions with immunotherapies;Journal of Neuro-Oncology;2021-01-03

5. Molecular and Immunologic Signatures are Related to Clinical Benefit from Treatment with Vocimagene Amiretrorepvec (Toca 511) and 5-Fluorocytosine (Toca FC) in Patients with Glioma;Clinical Cancer Research;2020-08-18